Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.

A recent article in the journal Nature Communications describes the structural basis of mimicked HBV/HDV viral peptide drug interaction with its receptor NTCP. HBV, an enveloped DNA virus, causes ...

Hepatitis B virus infections can progress from an ... 74% base pairing to form an unbranched rod-like structure. The genome sequence shows no homology to the 3300-nucleotide genome of a hepadnavirus.

However, I was fascinated to discover that viruses like hepatitis B hijack epigenetic mechanisms, even using human DNA-packaging proteins to regulate their activity.” Not long after, study first ...

one of the smallest DNA viruses in existence, enters susceptible liver cells — known as hepatocytes — and begins replicating. Inside the hepatocytes, HBV produces a surplus of viral antigens ...

ELIMINATE-B Phase 1 dose finding study for chronic Hepatitis B ... genome editing platform that differs from other technologies in the way it cuts, its smaller size, and its simpler structure.